Gary G. Chicchi

4.7k citations

65 papers · 2.5k indexed · h-index 29

Molecular Biology top 5%
Endocrinology, Diabetes and Metabolism top 1%
Cellular and Molecular Neuroscience top 2%
Organic Chemistry top 5%
Surgery top 10%

Co-authors: Margaret A. Cascieri Marvin Bayne Joy Applebaum Nancy S. Hayes Marc M. Kurtz Barbara G. Green Sharon Sadowski Christopher J. Swain
Topics: Neuropeptides and Animal Physiology (32 papers)Receptor Mechanisms and Signaling (30 papers)Growth Hormone and Insulin-like Growth Factors (12 papers)
Cited by: Endocrinology, Diabetes and Metabolism Cellular and Molecular Neuroscience Molecular Biology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Circulation Research
Partner nations: United States United Kingdom Austria

In The Last Decade

Gary G. Chicchi

65 papers receiving 2.4k citations

Peers

Countries citing papers authored by Gary G. Chicchi

Since Specialization

Citations

This map shows the geographic impact of Gary G. Chicchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary G. Chicchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary G. Chicchi more than expected).

Fields of papers citing papers by Gary G. Chicchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary G. Chicchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary G. Chicchi. The network helps show where Gary G. Chicchi may publish in the future.

Co-authorship network of co-authors of Gary G. Chicchi

This figure shows the co-authorship network connecting the top 25 collaborators of Gary G. Chicchi. A scholar is included among the top collaborators of Gary G. Chicchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary G. Chicchi. Gary G. Chicchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of substituted (4-phenyl-1H-imidazol-2-yl)methanamine as potent somatostatin receptor 3 agonists 2015 ·Bioorganic & Medicinal Chemistry Letters ·Zhong Lai,Shuwen He,Edward C. Sherer,Zhicai Wu,(unknown),Richard Ball,Qingmei Hong,David Yang,(unknown),Derun Li,(unknown),Gary G. Chicchi,(unknown),Kwei‐Lan Tsao,Yunping Zhou,Andrew D. Howard,Ravi P. Nargund,William K. Hagmann	2
2	The Glucagon Receptor Is Involved in Mediating the Body Weight‐Lowering Effects of Oxyntomodulin 2012 ·Obesity ·Jennifer Kosinski,James Hubert,Paul E. Carrington,Gary G. Chicchi,James Mu,Corey Miller,Jin Cao,Elisabetta Bianchi,Antonello Pessi,Ranabir SinhaRoy,Donald J. Marsh,Alessandro Pocai	90
3	Optimization of co‐agonism at GLP‐1 and glucagon receptors to safely maximize weight reduction in DIO‐rodents 2012 ·Biopolymers ·Jonathan W. Day,Vasily M. Gelfanov,David L. Smiley,Paul E. Carrington,George J. Eiermann,Gary G. Chicchi,Mark D. Erion,(unknown),Nancy A. Thornberry,Matthias H. Tschöp,Donald J. Marsh,Ranabir SinhaRoy,Richard D. DiMarchi,Alessandro Pocai	111
4	Design of potent and selective GPR119 agonists for type II diabetes 2010 ·Bioorganic & Medicinal Chemistry Letters ·Jason W. Szewczyk,John J. Acton,Alan D. Adams,Gary G. Chicchi,Stanley K. Freeman,Andrew D. Howard,Yong Huang,Cai Li,Peter T. Meinke,(unknown),Elizabeth Murphy,(unknown),Conrad Santini,Meng Yang,Yong Zhang,(unknown),Harold B. Wood	21
5	Substituted fused bicyclic pyrrolizinones as potent, orally bioavailable hNK1 antagonists 2010 ·Bioorganic & Medicinal Chemistry Letters ·Gregori J. Morriello,Sander G. Mills,(unknown),Mikhail Reibarkh,Gary G. Chicchi,Julie A. DeMartino,Marc M. Kurtz,Philip R. Davies,(unknown),Song Guo Zheng,Xinchun Tong,Emma Carlson,(unknown),F.D. Tattersall,Alan Wheeldon,Susan Boyce,Neil Collinson,N.M.J. Rupniak,Stephen Moore,Robert J. DeVita	8
6	Modulation of basal and stress‐induced amygdaloid substance P release by the potent and selective NK1 receptor antagonist L‐822429 2008 ·Journal of Neurochemistry ·Nicolas Singewald,Gary G. Chicchi,(unknown),Kwei‐Lan Tsao,Mariana Spetea,Helmut Schmidhammer,(unknown),Francesco Ferraguti,Georg M. Singewald,Karl Ebner	45
7	The discovery of potent, selective, and orally bioavailable hNK1 antagonists derived from pyrrolidine 2007 ·Bioorganic & Medicinal Chemistry Letters ·Peter Lin,(unknown),Robert J. DeVita,Jonathan R. Young,(unknown),Xinchun Tong,Song Guo Zheng,Richard G. Ball,Nancy N. Tsou,Gary G. Chicchi,Marc M. Kurtz,Kwei‐Lan Tsao,Alan Wheeldon,Emma Carlson,Waisi Eng,H. Donald Burns,Richard Hargreaves,Sander G. Mills	11
8	Fused bicyclic pyrrolizinones as new scaffolds for human NK1 antagonists 2007 ·Bioorganic & Medicinal Chemistry ·Gregori J. Morriello,Robert J. DeVita,Sander G. Mills,Jonathan R. Young,Peter Lin,George A. Doss,Gary G. Chicchi,Julie A. DeMartino,Marc M. Kurtz,Kwei‐Lan Tsao,Emma Carlson,(unknown),Alan Wheeldon,Susan Boyce,Neil Collinson,N.M.J. Rupniak,Stephen Moore	24
9	NK1 antagonists based on seven membered lactam scaffolds 2006 ·Bioorganic & Medicinal Chemistry Letters ·Jason Elliott,Emma Carlson,Gary G. Chicchi,Olivier Dirat,María Domínguez,Ute Gerhard,Richard A. Jelley,A. Brian Jones,Marc M. Kurtz,(unknown),Alan Wheeldon	15
10	1-Phenyl-8-azabicyclo[3.2.1]octane ethers: A novel series of neurokinin (NK1) antagonists 2006 ·Bioorganic & Medicinal Chemistry Letters ·Ian T. Huscroft,Emma Carlson,Gary G. Chicchi,Marc M. Kurtz,Clare London,Piotr Raubo,Alan Wheeldon,Janusz J. Kulagowski	18
11	N′,2-Diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists II 2006 ·Bioorganic & Medicinal Chemistry Letters ·Jason Elliott,Robert W. Carling,Gary G. Chicchi,James Crawforth,Peter H. Hutson,A. Brian Jones,Sarah Kelly,Rose Marwood,Georgina Meneses‐Lorente,(unknown),Fraser Murray,Michael Rigby,Inmaculada Royo,Michael G. N. Russell,Duncan Shaw,Bindi Sohal,(unknown),Brian J. Williams	15
12	4,4-Disubstituted cyclohexylamine NK1 receptor antagonists II 2002 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Emma Carlson,José L. Castro,Gary G. Chicchi,(unknown),Jerry Di Salvo,Jason Elliott,Gregory J. Hollingworth,Marc M. Kurtz,Mark P. Ridgill,Wayne Rycroft,Kwei‐Lan Tsao,Christopher J. Swain	16
13	Chronic substance P (NK1) receptor antagonist and conventional antidepressant treatment increases burst firing of monoamine neurones in the locus coeruleus 2002 ·Neuroscience ·Karen Maubach,Karine Martin,Gary G. Chicchi,Timothy Harrison,Alan Wheeldon,Christopher J. Swain,M. Cumberbatch,N.M.J. Rupniak,Guy R. Seabrook	60
14	2-Aryl indole NK1 antagonists: optimisation of the amide substituent 2001 ·Bioorganic & Medicinal Chemistry Letters ·Duncan Shaw,Gary G. Chicchi,Jason Elliott,Marc M. Kurtz,Denise Morrison,Mark P. Ridgill,(unknown),Alan P. Watt,Angela Williams,Christopher J. Swain	10
15	Serine derived NK1 antagonists 1: The effect of modifications to the serine substituents 1998 ·Bioorganic & Medicinal Chemistry Letters ·Jason Elliott,Margaret A. Cascieri,Gary G. Chicchi,Stephen J. Davies,Fintan Kelleher,Marc M. Kurtz,T. Ladduwahetty,Richard T. Lewis,Angus M. MacLeod,Kevin J. Merchant,Sharon Sadowski,Graeme I. Stevenson	7
16	Alterations in Receptor Activation and Divalent Cation Activation of Agonist Binding by Deletion of Intracellular Domains of the Glucagon Receptor 1997 ·Journal of Biological Chemistry ·Gary G. Chicchi,Michael P. Graziano,(unknown),Patricia J. Hey,Kathleen A. Sullivan,Pasquale P. Vicario,Margaret A. Cascieri	25
17	Cloning and Functional Expression of a Human Glucagon-like Peptide-1 Receptor 1993 ·Biochemical and Biophysical Research Communications ·M P Graziano,Patricia J. Hey,(unknown),Gary G. Chicchi,Catherine D. Strader	49
18	Characterization of the Biological Activity of IGF I Analogs with Reduced Affinity for IGF Receptors and Binding Proteins 1991 ·Advances in experimental medicine and biology ·Margaret A. Cascieri,Gary G. Chicchi,Marvin Bayne	6
19	Serum Half-Life and Biological Activity of Mutants of Human Insulin-Like Growth Factor I which Do Not Bind to Serum Binding Proteins 1988 ·Endocrinology ·Margaret A. Cascieri,Richard Saperstein,Nancy S. Hayes,Barbara G. Green,Gary G. Chicchi,Joy Applebaum,Marvin Bayne	56
20	Inability of a Mouse Cell Line Transformed to Produce Biologically Active Recombinant Human Insulin-Like Growth Factor I (IGF-I) to Respond to Exogenously Added IGF-I 1988 ·Endocrinology ·Margaret A. Cascieri,Nancy S. Hayes,Bruce Kelder,John J. Kopchick,Gary G. Chicchi,Eve E. Slater,Marvin Bayne	8

About Gary G. Chicchi

Gary G. Chicchi is a scholar working on Cellular and Molecular Neuroscience, Endocrinology, Diabetes and Metabolism and Toxicology, having authored 65 papers that have together received 2.5k indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (32 papers), Receptor Mechanisms and Signaling (30 papers) and Growth Hormone and Insulin-like Growth Factors (12 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (862 citations), Cellular and Molecular Neuroscience (784 citations) and Molecular Biology (1.5k citations). Gary G. Chicchi has collaborated with scholars based in United States, United Kingdom and Austria. Frequent co-authors include Margaret A. Cascieri, Marvin Bayne, Joy Applebaum, Nancy S. Hayes, Marc M. Kurtz, Barbara G. Green, Sharon Sadowski, Christopher J. Swain, Kwei‐Lan Tsao and Angela Williams. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact